期刊文献+

应用新型抗组胺药依巴斯汀治疗慢性荨麻疹临床疗效观察

Usage of Ebastine in chronic hiver
下载PDF
导出
摘要 目的探讨依巴斯汀治疗慢性荨麻疹的疗效。方法将54例慢性荨麻疹患者随机分为两组,试验组给予口服依巴斯汀,对照组患者口服西替利嗪。结果试验组痊愈12例,显效11例,有效4例,无效1例,总有效率为82.1%。对照组痊愈10例,显效8例,有效3例,无效5例,总有效率为69.2%。结论口服依巴斯汀治疗慢性荨麻疹疗法明显优于西替利嗪且不良反应少。 Objective To explore the efficacy of Ebastine to chronic hives, Methods 54 cases of chronic hives were devided into two groups. In treatment group, patients were treated with Ebastine and Cetifizine was used in control group. Results In treatment group, 12 cases were cured, remarkable effect for 11 patients, moderate effect for 4 patients, no effect for 1 patient, The total effective rate was 82. 1%. In control group, 10 patients were cured, remarkable effect for 8 patients, moderate effect for 3 patients, no effect for 5 patients, the total effective rate was 69.2%. Conlusion Ebastine is effective and less adverse effect to chronic hives.
机构地区 犍为县人民医院
出处 《现代保健(医学创新研究)》 2008年第6期15-15,共1页
关键词 慢性荨麻疹 依巴斯汀 临床疗效 Chronic hives Ebastine Clinical efficacy
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部